Details of the Drug

General Information of Drug (ID: DMKF1O2)

• Drug Name: AMG 119

Indication

Disease Entry	ICD 11	Status	REF
Small-cell lung cancer	2C25.Y	Phase 1	[1]

• Drug Type: CAR T Cell Therapy
• Cross-matching ID: TTD ID: D9FGB3

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Delta-like protein 3 (DLL3)	TT1C9K6	DLL3_HUMAN	Inhibitor	[2]

References

• [1] ClinicalTrials.gov (NCT03392064) A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
• [2] Clinical pipeline report, company report or official report of Amgen.